Protracted exposure radiosensitization of experimental human malignant glioma

Radiation Oncology Investigations

Volumn 6, Issue 6, 1998, Pages 255-263

  Williams, Jeffery A ^a,b   Williams, Jerry R ^a   Yuan, Xuan ^a   Dillehay, Larry E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Low dose rate radiation; Malignant glioma; Radiosensitivity; Radiotherapy; Xenograft

Indexed keywords

CESIUM 137; IODINE 125;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BRACHYTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL KILLING; GLIOBLASTOMA; HUMAN; HUMAN CELL; LOW ENERGY RADIATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIOSENSITIZATION;

ANIMALS; BRACHYTHERAPY; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032441966     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:6<255::AID-ROI2>3.0.CO;2-K     Document Type: Article

References (32)

1. Kornblith PL, Walker M. Chemotherapy for malignant gliomas [published erratum appears in J Neurosurg 1988;69:645]. J Neurosurg 1988;68:1-17.
2. Kornblith PL. The role of cytotoxic chemotherapy in the treatment of malignant brain tumors. Surg Neurol 1995;44:551-552.
3. Sneed PK, Prados MD, McDermott MW, Larson DA, Malec MK, Lamborn KR, Davis RL, Weaver KA, Wara WM, Phillips TL, et al. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 1995;36:898-894.
4. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. JNCI 1993;85:704-710.
5. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49:333-343.
6. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5: 1725-1731.
7. Sneed PK, Lamborn KR, Larson DA, Prados MD, Malec MK, McDermott MW, Weaver KA, Phillips TL, Wara WM, Gutin PH. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1996;35:37-44.
8. Siddiqi SN, Provias J, Laperriere N, Bernstein M. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy. Neurosurgery 1997;40: 910-918.
9. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, et al. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992;24:583-591.
10. Zamorano L, Yakar D, Dujovny M, Sheehan M, Kim J. Permanent iodine-125 implant and external beam radiation therapy for the treatment of malignant brain tumors. Stereotact Funct Neurosurg 1992;59:183-192.
11. Fernandez PM, Zamorano L, Yakar D, Gaspar L, Warmelink C. Permanent iodine-125 implants in the up-front treatment of malignant gliomas. Neurosurgery 1995:36:467-473.
12. Marin LA, Smith CE, Langston MY, Quashie D, Dillehay LE. Response of glioblastoma cell lines to low dose rate irradiation. Int J Radiat Oncol Biol Phys 1991;21:397-402.
13. Williams JR, Zhang YG, Dillehay LE. Sensitization processes in human tumor cells during protracted irradiation: possible exploitation in the clinic. Int J Radiat Oncol Biol Phys 1992;24:699-704.
14. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radio 1989;62:679-694.
15. Mayer R, Dillehay LE, Shao Y, Song S, Zhang YG, Bartholomew RM, Williams JR. A new method for determining dose rate distribution from radioimmunotherapy using radiochromic media. Int J Radiat Oncol Biol Phys 1994;28:505-513.
16. Williams JA, Edwards JA, Dillehay LE. Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts. Int J Radiat Oncol Biol Phys 1992;24:111-117.
17. Malaise EP, Fertil B, Chavaudra N, Guichard M. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data. Int J Radiat Oncol Biol Phys 1986;12:617-624.
18. Malaise EP, Fertil B, Deschavanne PJ, Chavaudra N, Brock WA. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat Res 1987;111:319-333.
19. Allalunis-Turner MJ, Zia PK, Barron GM, Mirzayans R, Day RS III. Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. Radiat Res 1995;144:288-293.
20. Taghian A, DuBois W, Budach W, Baumann M, Freeman J, Suit H. In vivo radiation sensitivity of glioblastoma multiforme, Int J Radiat Oncol Biol Phys 1995;32:99-104.
21. Buronfosse A, Thomas CP, Ginestet C, Dore JF. Radiosensitivity in vitro of clonogenic and non-clonogenic glioblastoma cells obtained from a human brain tumour. C R Acad Sci [III] 1994;317:1031-1041.
22. Ramsay J, Ward R, Bleehen NM. Radiosensitivity testing of human malignant gliomas. Int J Radiat Oncol Biol Phys 1992;24:675-680.
23. McLaughlin PW, Mancini WR, Stetson PL, Greenberg HS, Nguyen N, Seabury H, Heidorn DB, Lawrence TS. Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. Int J Radiat Oncol Biol Phys 1993;26:637-642.
24. Thames HD. An "incomplete-repair" model for survival after fractionated and continuous irradiations. Int J Radiat Biol 1985;47:319-339.
25. Schultz CJ, Geard CR. Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Oncol Biol Phys 1990;19:1397-1403.
26. Mitchell JB, Bedord JS, Bailey SM. Dose-rate effects on the cell cycle and survival of S3 HeLa and V79 cells. Radiat Res 1979;79:520-536.
27. Peacock JH, Eady JJ, Edwards SM, McMillan TJ, Steel GG. The intrinsic alpha/beta ratio for human tumour cells: is it a constant? Int J Radiat Biol 1992;61:479-487.
28. Nath R, Meigooni AS, Muench P, Melillo A. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources. Med Phys 1993;20:1465-1473.
29. Lindegaard JC, Overgaard J, Bentzen SM, Pedersen D. Is there a radiobiologic basis for improving the treatment of advanced stage cervical cancer? JNCI Monogr 1996;21:105-112.
30. Fritz P, Weber KJ, Frank C, Flentje M. Differential effects of dose rate and superfractionation on survival and cell cycle of V79 cells from spheroid and monolayer culture. Radiother Oncol 1996;39:73-79.
31. Baumann M, DuBois W, Pu A, Freeman J, Suit HD. Response of xenografts of human malignant gliomas and squamos cell carcinomas to fractionated irradiation. Int J Radiat Oncol Biol Phys 1992;23:803-809.
32. Marcial-Vega VA, Wharam MD, Leibel S, Clark A, Zweig R, Order SE. Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1989;16:1419-1424.